Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemia. Paul SR, Rosing DR, Haigney MC, Peer CJ, et al. Br J Haematol 2023;200:261-263.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Paul SR, Rosing DR, Haigney MC, Peer CJ, et al. Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemia. Br J Haematol 2023;200:261-263.
PMID: 36366824